Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.

Saved in:
Bibliographic Details
Title: Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, randomized, parallel arm study.
Authors: Younis, Brima Musa1 (AUTHOR), Mudawi Musa, Ahmed1 (AUTHOR), Monnerat, Séverine2 (AUTHOR), Abdelrahim Saeed, Mohammed1 (AUTHOR), Awad Gasim Khalil, Eltahir1 (AUTHOR), Elbashir Ahmed, Anas1 (AUTHOR), Ahmed Ali, Mujahid1 (AUTHOR), Noureldin, Ali1 (AUTHOR), Muthoni Ouattara, Gina3 (AUTHOR), Nyakaya, Godfrey M.3 (AUTHOR), Teshome, Samuel3 (AUTHOR), Omollo, Truphosa3 (AUTHOR), Ochieng, Michael3 (AUTHOR), Egondi, Thaddaeus3 (AUTHOR), Mmbone, Mildred3 (AUTHOR), Chu, Wan-Yu4 (AUTHOR), Dorlo, Thomas P. C.5 (AUTHOR), Zijlstra, Eduard E.2 (AUTHOR), Wasunna, Monique3 (AUTHOR), Alvar, Jorge2 (AUTHOR)
Source: PLoS Neglected Tropical Diseases. 11/21/2023, Vol. 17 Issue 11, p1-20. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19352727
DOI:10.1371/journal.pntd.0011780